These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 16697867)
41. Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid. Zhu J; Ai Q; Cheng Q; Shen D; Dong Z; Li J; Shen D; Wang W; Zhang X; Li H Front Oncol; 2022; 12():990023. PubMed ID: 36185218 [TBL] [Abstract][Full Text] [Related]
42. On the emergence of multifocal cancers. Wodarz D; Iwasa Y; Komarova NL J Carcinog; 2004 Oct; 3(1):13. PubMed ID: 15461783 [TBL] [Abstract][Full Text] [Related]
43. Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma. Lee JH; Lee CU; Chung JH; Song W; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Sung HH Cancer Res Treat; 2024 Jul; 56(3):877-884. PubMed ID: 38271926 [TBL] [Abstract][Full Text] [Related]
44. Intravesical Therapy for Upper Urinary Tract Urothelial Carcinoma: A Comprehensive Review. Wang Z; Shi H; Xu Y; Fang Y; Song J; Jiang W; Xia D; Wu Z; Wang L Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894387 [TBL] [Abstract][Full Text] [Related]
45. Attachment of Cancer Urothelial Cells to the Bladder Epithelium Occurs on Uroplakin-Negative Cells and Is Mediated by Desmosomal and Not by Classical Cadherins. Jerman UD; Višnjar T; Bratkovič IH; Resnik N; Pavlin M; Veranič P; Kreft ME Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070317 [TBL] [Abstract][Full Text] [Related]
46. The nephroureterectomy: a review of technique and current controversies. Barton GJ; Tan WP; Inman BA Transl Androl Urol; 2020 Dec; 9(6):3168-3190. PubMed ID: 33457289 [TBL] [Abstract][Full Text] [Related]
47. A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study. Huang Y; Cen J; Liu Z; Wei J; Chen Z; Feng Z; Lu J; Fang Y; Zhou F; Luo J; Mo C; Chen W Technol Cancer Res Treat; 2019 Jan; 18():1533033819844483. PubMed ID: 30987527 [TBL] [Abstract][Full Text] [Related]
48. Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma. Miyake M; Owari T; Hori S; Nakai Y; Fujimoto K Res Rep Urol; 2018; 10():251-261. PubMed ID: 30588457 [TBL] [Abstract][Full Text] [Related]
49. Prognostic value of AIB1 and EIF5A2 in intravesical recurrence after surgery for upper tract urothelial carcinoma. Huang Y; Wei J; Fang Y; Chen Z; Cen J; Feng Z; Lu J; Liang Y; Luo J; Chen W Cancer Manag Res; 2018; 10():6997-7011. PubMed ID: 30588104 [TBL] [Abstract][Full Text] [Related]
50. High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment? Mekayten M; Yutkin V; Duvdevani M; Pode D; Hidas G; Landau EH; Youssef F; Gofrit ON Res Rep Urol; 2018; 10():33-38. PubMed ID: 29872646 [TBL] [Abstract][Full Text] [Related]
51. Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum. Thomas ML; Marcato P Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29614786 [TBL] [Abstract][Full Text] [Related]
53. The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. Kishimoto N; Takao T; Kuribayashi S; Yamamichi G; Nakano K; Kawamura M; Tsutahara K; Tanigawa G; Yamaguchi S Int J Clin Oncol; 2017 Feb; 22(1):153-158. PubMed ID: 27614622 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma is Independently Associated with Intravesical Recurrence after Radical Nephroureterectomy. Liu P; Su XH; Xiong GY; Li XS; Zhou LQ Int Braz J Urol; 2016; 42(6):1129-1135. PubMed ID: 27509369 [TBL] [Abstract][Full Text] [Related]
55. Dynamic Change in p63 Protein Expression during Implantation of Urothelial Cancer Clusters. Yoshida T; Okuyama H; Nakayama M; Endo H; Tomita Y; Nonomura N; Nishimura K; Inoue M Neoplasia; 2015 Jul; 17(7):574-85. PubMed ID: 26297435 [TBL] [Abstract][Full Text] [Related]
56. Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract. Deng X; Yang X; Cheng Y; Liu X; Wu B; Wang Z; Huang Z; Liu K; Zhao R; Wang J; Lu Q; Qin C; Yin C Int J Clin Exp Med; 2014; 7(12):4734-46. PubMed ID: 25663970 [TBL] [Abstract][Full Text] [Related]
57. Bladder cancer: a simple model becomes complex. Di Pierro GB; Gulia C; Cristini C; Fraietta G; Marini L; Grande P; Gentile V; Piergentili R Curr Genomics; 2012 Aug; 13(5):395-415. PubMed ID: 23372425 [TBL] [Abstract][Full Text] [Related]
58. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours. Yates DR; Catto JW World J Urol; 2013 Feb; 31(1):21-9. PubMed ID: 22986906 [TBL] [Abstract][Full Text] [Related]
59. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. Cosentino M; Palou J; Gaya JM; Breda A; Rodriguez-Faba O; Villavicencio-Mavrich H World J Urol; 2013 Feb; 31(1):141-5. PubMed ID: 22552732 [TBL] [Abstract][Full Text] [Related]